Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Baylor College of Medicine and UH team up for new research collaborations

Baylor College of Medicine and the University of Houston are teaming up for new research collaborations.

10 Mar 2020

Research introduces a new concept of resectability in pancreatic cancer

Pancreatic cancer is predicted to become the second leading cause of cancer-related deaths by 2030. However, recent developments in staging and treatment provide options to improve the long-term survival rate for an otherwise devastating diagnosis.

10 Mar 2020

NCCN publishes recommendations for assessing quality improvements in cancer care

The National Comprehensive Cancer Network has published a curated list of high-impact measures for assessing quality improvements in cancer care.

10 Mar 2020

Research reveals bias and stereotyping when recruiting patients for oncology clinical trials

New research reveals bias and stereotyping among clinical and research professionals who recruit patients to enroll in cancer clinical trials. The findings are published early online in CANCER, a peer-reviewed journal of the American Cancer Society.

10 Mar 2020

Lung cancer mortality could be reduced by including smoking cessation with screening

Including smoking cessation with existing lung cancer screening efforts would reduce lung cancer mortality by 14 percent and increase life-years gained by 81 percent compared with screening alone, according to a study from Rafael Meza from the University of Michigan and colleagues and published in the Journal of Thoracic Oncology, a publication of the International Association for the Study of Lung Cancer.

9 Mar 2020

'Primitive' stem cells shown to replace and repair damaged blood vessels in the retina

Johns Hopkins Medicine scientists say they have successfully turned back the biological hands of time, coaxing adult human cells in the laboratory to revert to a primitive state, and unlocking their potential to replace and repair damage to blood vessels in the retina caused by diabetes.

9 Mar 2020

New toolkit to repair DNA breaks linked to aging, cancer and MND discovered

A new 'toolkit' to repair damaged DNA that can lead to aging, cancer and Motor Neurone Disease has been discovered by scientists at the Universities of Sheffield and Oxford.

9 Mar 2020

Investigational CAR-T therapy for Hodgkin lymphoma receives fast-track designation from FDA

Based on proof-of-concept results from clinical trials at University of North Carolina Lineberger Comprehensive Cancer Center and Baylor College of Medicine, an investigational cellular immunotherapy for Hodgkin lymphoma has received a Regenerative Medicine Advanced Therapy designation from the U.S. Food and Drug Administration.

9 Mar 2020

Study reveals bias and stereotyping when enrolling patients in cancer clinical trials

New research reveals bias and stereotyping among clinical and research professionals who recruit patients to enroll in cancer clinical trials.

9 Mar 2020

New 'Immuno-Engineering to Improve Immunotherapy' Center formed to advance cancer therapy

Harvard University's Wyss Institute of Biologically Inspired Engineering and its collaborating institutions, the Harvard John A. Paulson School of Engineering and Applied Sciences, Dana-Farber Cancer Institute, and Harvard's Department of Stem Cell and Regenerative Biology, announce the formation of a new NIH-funded Immuno-Engineering to Improve Immunotherapy Center.

7 Mar 2020

Aggressive features in papillary thyroid microcarcinoma raises the risk for distant metastasis

Although papillary thyroid carcinoma is the most common form of thyroid malignancy, it is considered to be an indolent disease that progresses slowly and has an excellent prognosis.

6 Mar 2020

New technique to distinguish freshly made transcripts from pre-existing transcripts

Our bodies consist of trillions of cells that all contain the same DNA. Even though the DNA in each cell is the same, we consist of many different cell types, each with different functions.

6 Mar 2020

Molecule-sized drills can target diseased cells and kill them in minutes

Molecule-sized drills do the damage they are designed to do. That's bad news for disease.

5 Mar 2020

Deep learning algorithm to enhance mammography screening interpretation

The study is based on the results obtained in the Digital Mammography DREAM Challenge, an international competition led by IBM where researchers from the Instituto de Física Corpuscular have participated along with scientists from the UPV's Institute of Telecommunications and Multimedia Applications.

5 Mar 2020

New type of adoptive cell therapy could target prostate and pancreatic cancers in humans

In experiments with mice, researchers at the Johns Hopkins Kimmel Cancer Center say they have slowed the growth of transplanted human prostate and pancreatic cancer cells by introducing bone marrow cells with a specific gene deletion to induce a novel immune response.

5 Mar 2020

Study provides new evidence about optimal way to treat BRCA carriers with breast cancer

Commonly known as the breast cancer genes, the BRCA gene family plays a role in repairing damaged DNA. Inherited mutations in the genes BRCA1 or BRCA2 raise the risk of developing breast, ovarian, prostate and other cancers.

5 Mar 2020

New approach may lead to targeted treatments for certain macrophages or their mechanisms

Can phagocytes act like a Trojan horse, transporting tumour cells within themselves and thereby causing metastases in cancer patients?

5 Mar 2020

Combined biopsy more likely to detect aggressive prostate cancers than standard biopsy alone

Using a combination of magnetic resonance imaging (MRI) to target and sample suspicious prostate tissue along with a standard prostate biopsy is significantly more likely to detect the most aggressive prostate cancers than standard biopsy alone.

5 Mar 2020

Being overweight linked to greater risk of advanced prostate cancer

A new study links being overweight in middle age and later adulthood to a greater risk of advanced prostate cancer.

4 Mar 2020

The research and development costs of a new drug

Many recent studies have focused on how much it costs to bring a new drug to market in the light of increasing drug prices. Estimates range from $314 million to $2.8 billion. Most of this was based on proprietary data and was, therefore, not verifiable independently, attracting much criticism.

3 Mar 2020

Oncology News and Research

Further Reading

Baylor College of Medicine and UH team up for new research collaborations

Research introduces a new concept of resectability in pancreatic cancer

NCCN publishes recommendations for assessing quality improvements in cancer care

Research reveals bias and stereotyping when recruiting patients for oncology clinical trials

Lung cancer mortality could be reduced by including smoking cessation with screening

'Primitive' stem cells shown to replace and repair damaged blood vessels in the retina

New toolkit to repair DNA breaks linked to aging, cancer and MND discovered

Investigational CAR-T therapy for Hodgkin lymphoma receives fast-track designation from FDA

Study reveals bias and stereotyping when enrolling patients in cancer clinical trials

New 'Immuno-Engineering to Improve Immunotherapy' Center formed to advance cancer therapy

Aggressive features in papillary thyroid microcarcinoma raises the risk for distant metastasis

New technique to distinguish freshly made transcripts from pre-existing transcripts

Molecule-sized drills can target diseased cells and kill them in minutes

Deep learning algorithm to enhance mammography screening interpretation

New type of adoptive cell therapy could target prostate and pancreatic cancers in humans

Study provides new evidence about optimal way to treat BRCA carriers with breast cancer

New approach may lead to targeted treatments for certain macrophages or their mechanisms

Combined biopsy more likely to detect aggressive prostate cancers than standard biopsy alone

Being overweight linked to greater risk of advanced prostate cancer

The research and development costs of a new drug

Event guide: 10th CAR-TCR Summit eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News